Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of Gastric Adenocarcinoma in Comparison With the Sixth Classification

被引:193
作者
Ahn, Hye Seong
Lee, Hyuk Joon
Hahn, Seokyung [2 ]
Kim, Woo Ho [3 ]
Lee, Kuhn Uk
Sano, Takeshi [4 ]
Edge, Stephen B. [5 ]
Yang, Han-Kwang [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Surg, Canc Res Inst, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Med Res Collaborating Ctr, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110744, South Korea
[4] Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[5] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA
关键词
gastric adenocarcinoma; American Joint Committee on Cancer/International Union Against Cancer; Classification; survival; pathology; surgery; LYMPH-NODE METASTASIS; CARCINOMA; SUBCLASSIFICATION;
D O I
10.1002/cncr.25550
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND The seventh TNM staging system for gastric cancer of the American Joint Committee on Cancer/International Union Against Cancer (AJCC/UICC) had a more detailed classification than the sixth TNM staging system for both the tumor (T) and lymph nodes (N) The authors compared survival rates assessed by the seventh staging system with those by the sixth system METHODS The authors analyzed the prospectively collected database on patients with gastric cancer who underwent surgery at Seoul National University Hospital between 1986 and 2006 and calculated the survival rates of 9998 cases with primary cancer RO resection and >14 retrieved lymph nodes RESULTS The 5-year cumulative survival rates (5YSR) according to the seventh edition T or N classifications were significantly different The 5YSR according to seventh edition of the TNM staging system were 95 1% (stage IA) 88 4% (stage IB) 84 0% (stage IIA) 71 7% (stage IIB) 58 4% (stage IIIA) 41 3% (stage IIIB) and 26 1% (stage IIIC) which were significantly different from each other The 5YSR of the seventh edition T2 and 13 classifications had significant differences in patients with every N classification and the 5YSR of seventh edition N1 and N2 classifications had significant differences in T2 patients T3 patients and T4 patients Each stage in the sixth edition was divided into the seventh edition stage with different survival rates In addition the number of homogenous groupings in seventh edition TNM stages was increased from 1 to 2 CONCLUSIONS The seventh system provided a more detailed classification of prognosis than the sixth system especially between T2 and T3 tumors and N1 and N2 tumors although further studies were found to be needed for the N3a and N3b classification Cancer 2010,116 5592-8 (C) 2010 American Cancer Society
引用
收藏
页码:5592 / 5598
页数:7
相关论文
共 13 条
  • [1] [Anonymous], 2010, AJCC CANC STAGING MA
  • [2] Greene F., 2002, AJCC cancer staging handbook: From the AJCC cancer staging manual, V6th
  • [3] Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO
  • [4] 2-D
  • [5] Kodera Y, 1998, J SURG ONCOL, V69, P15, DOI 10.1002/(SICI)1096-9098(199809)69:1<15::AID-JSO4>3.0.CO
  • [6] 2-N
  • [7] 2 HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA - DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA - AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION
    LAUREN, P
    [J]. ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1965, 64 (01): : 31 - &
  • [8] Prognostic significance of subclassification of pT2 gastric cancer: A retrospective study of 847 patients
    Lu, Yang
    Liu, Caigang
    Zhang, Ruishan
    Li, Hua
    Lu, Ping
    Jin, Feng
    Xu, Huimian
    Wang, Shubao
    Chen, Junqing
    [J]. SURGICAL ONCOLOGY-OXFORD, 2008, 17 (04): : 317 - 322
  • [9] Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs pT2b) and lymph node status (pN)
    Park, Do Joong
    Kong, Seong-Ho
    Lee, Hyuk-Joon
    Kim, Woo Ho
    Yang, Han-Kwang
    Lee, Kuhn Uk
    Choe, Kuk Jin
    [J]. SURGERY, 2007, 141 (06) : 757 - 763
  • [10] Roder JD, 1998, CANCER-AM CANCER SOC, V82, P621, DOI 10.1002/(SICI)1097-0142(19980215)82:4<621::AID-CNCR2>3.3.CO